ABSTRACT. The fibroblast of the fetal and neonatal lung is intimately involved with lung development and function. Additionally, the perinatal rat lung fibroblast is a significant source of prostaglandins (PG) I2 and E2, which in turn affect lung development and function. Their effects may be mediated by CAMP. We, therefore, tested both the relative effectiveness of PG and the 8-adrenergic agonist, isoproterenol, and the developmental age sensitivity to these agonists on rat perinatal lung fibroblast cAMP accumulation. Confluent monolayer cultures of 3rd-passage fibroblasts (>95% purity) from d-3 newborn rats responded in a concentration-dependent fashion to several PG (lo-'-M) and isoproterenol (lO-'-2 x M) by increasing cAMP accumulation. The rank order of responsiveness, in terms of maximum accumulated CAMP, were carba PGI2 > PGE, = PG12 Na salt = PG12 methyl ester > > PGEz > 
ABSTRACT. The fibroblast of the fetal and neonatal lung is intimately involved with lung development and function. Additionally, the perinatal rat lung fibroblast is a significant source of prostaglandins (PG) I2 and E2, which in turn affect lung development and function. Their effects may be mediated by CAMP. We, therefore, tested both the relative effectiveness of PG and the 8-adrenergic agonist, isoproterenol, and the developmental age sensitivity to these agonists on rat perinatal lung fibroblast cAMP accumulation. Confluent monolayer cultures of 3rd-passage fibroblasts (>95% purity) from d-3 newborn rats responded in a concentration-dependent fashion to several PG (lo- The fibroblast of the fetal and neonatal lung is an important cell in normal and abnormal lung function and development. In rats, it responds to glucocorticoid stimulation with the production of fibroblast pneumocyte factor (I), which in turn stimulates pneumocyte choline-phosphate cytidylyltransferase activity (2) . Also, fibroblasts are a source of extracellular matrix proteins, especially collagen types I and 111 (3, 4) , and thereby contribute to the morphology of the developing lung and its mechanical function.
Perinatal rat lung fibroblasts produce a number of PG in vitro (5). The most prevalent of these is prostacyclin (PGI?), as determined by its hydrolysis metabolite, 6-keto-PGF,,. PGE, is also produced by these cells, although at levels only about 25-30% of those of PG12. PGF2, is produced only at low rates. The ability of the fibroblast to produce PG is similar to that of perinatal rat lung endothelial cells, pneumocytes, (5, 6) or mixed lung cells (6) .
PG are known to have autocrine and paracrine actions in the lung. PGE, inhibits fibroblast proliferation and collagen synthesis in human fetal lung fibroblasts (7) . It is probable, therefore, that fibroblast PG may act in an autocrine or paracrine fashion to affect fibroblast function. One way by which PG effects upon the fibroblast may be mediated is via the second messenger, CAMP. Skinner et al. (8) demonstrated that PGE, stimulates changes in adenylate cyclase activity in fetal rat lung fibroblasts. Moreover, they found that cortisol enhances this responsiveness of fibroblasts to PGE2, which is suggestive of a maturational change induced by late gestational increases in circulating glucocorticoids. The purpose of this study, therefore, was to examine the responsiveness of perinatal rat lung fibroblasts, in terms of cAMP accumulation, to PG and the 0-adrenergic agonist, isoproterenol, at three different ages during a period of rapid pulmonary development.
MATERIALS AND METHODS

Materials.
Waymouth's Medium:Dulbecco's Minimal Essential Medium (I: 1, vol/vol) (medium), FCS, 0.05% trypsin (catalog no. 610-5300AG), and 0.2% EDTA were purchased from Gibco Canada, Burlington, Ontario, Canada. Isoproterenol (Isuprel) was obtained from Winthrop Pharmaceuticals, Aurora, Ontario, Canada. Iodinated 1251-cAMP and its antisera were a kind gift from Dr. D. Armstrong, Department of Obstetrics and Gynaecology and Physiology, University of Western Ontario (9) . The following items were purchased from Sigma Chemical Co., St. Louis, MO: cAMP free standard, BSA, IBMX, and DNase (catalog no. D4263). PGE,, PGE2, carba prostacyclin, and prostacyclin sodium salt were purchased from Cayman Chemical Company, Ann Arbor, MI. Prostacyclin methyl ester was purchased from Upjohn Co., Kalamazoo, MI.
Fibroblast cell culture preparation. Monolayer cultures of fi-broblast lung cells were prepared from perinatal rat pups at d 20 of gestation (term = 22 d), newborn d 1, or d 3, according to the procedure described by Tanswell et al. (10) . Briefly, timed pregnant rats (Long Evans x Sprague-Dawley, Charles River, Canada) were killed by excess chloroform, and the pups were decapitated in utero. Newborn pups were killed by decapitation. Midline thoracic incisions were made, and the lungs were removed. Lung tissues were placed in Dulbecco's PBS. The heart, vascular tissue, and airways were cut away, and the lungs were minced into 2-mm3 fragments. Cells were dispersed from the tissue by stimng in sterile 0.05% trypsin containing 0.2% EDTA and 50 pg/mL DNase for 15 min. The protease activity was stopped with 10% FCS (growth medium). The cells were then filtered through porous (100-pm) sterile nylon cloth, resuspended in 15 m L of growth medium, and centrifuged (SOI-vall) for 15 min at 1500 rpm at ambient temperature. The supernatant was removed, and the cells were resuspended in 10 mL of growth medium. The cells from an entire preparation were plated in a T80 flask (Coming) and incubated at 37°C for 1 h to allow for fibroblast adhesion. After this time, the cells were rinsed and reincubated with 10 mL growth medium at 37°C in a gas mixture consisting of 1 % 0 2 , 5% C02, and the balance N2. This procedure produces a medium Po2 of 4 +-0.5 kPa, which is close to the Po2 of fetal plasma (approximately 2.7 kPa) (6) . All cells from fetal and neonatal lungs were grown at 1 % O2 to maintain uniformity of procedure with all groups. Previous studies have shown that fetal rat lung fibroblasts have the greatest proliferation rate at 1 % 0 2 (1 1):
Media were changed every 48 h until confluence was reached (5-7 d after plating) as determined by phase contrast microscopy. At confluence, the cells were released from the flask (0.05% trypsin), resuspended in fresh growth medium, split in a 1 :3 ratio, and replated. This procedure was repeated to obtain 3rd-passage cells, which were plated in 6 x 4 well plates of 2 cm2 each for experimentation. Each well contained approximately 15 000 cells/cm2 as determined by automated cell counting (Coulter Electronics, Hialeah, FL). The purity of these cultures are >95% fibroblasts (5) .
The housing and handling of animals for this study was in strict adherence to the guidelines of the Canadian Council of Animal Care and was performed with the approval of the University Council on Animal Care.
Experimental protocols. At confluence and 24 h before experimentation, the media were removed and replaced with serumfree medium. All PG and isoproterenol were dissolved in Hanks' buffered saline solution containing 20 pM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (pH 7.38) and the phosphodiesterase inhibitor IBMX M). At the beginning of each experiment, serum-free medium was removed from the fibroblasts and replaced by Hanks' buffered saline solution with or without agonists. After a 15-min incubation period at 37°C in a water bath in room air, reactions were stopped by microwaving the cells (high power) for 42 s. Media were either frozen at -20°C for later assay or immediately assayed for cAMP and total protein.
Assays. Protein assays were performed using the Bradford technique (12) with BSA as the standard. cAMP determinations were made directly from the medium according to the RIA procedure of Brooker (13) . Samples (200 pL) were acetylated with 15 pL of triethy1amine:acetic anhydride (2: 1) before assaying t o enhance RIA sensitivity. Inasmuch as the cells released their cAMP into the medium upon boiling, the medium contained both cellular and released CAMP. The results reflect total cAMP accumulated during the incubation. The cAMP RIA has been validated and characterized by Reddoch et al. (9) .
Statistical analysis. Values are expressed as fmol cAMPlpg protein115 min. Results are expressed as mean a SD of three separate experiments. Each experiment was performed on cells obtained from separate litters of pups (five to 13 pups/litter) with four replications at each agonist concentration tested from each litter. The number of litters used in each experiment is described in the figure legends. The data in Figure 1 were analyzed separately for each agonist using one-way analysis of variance. In Figures 2 through 4 , the data were analyzed by a nested analysis of variation, in which the variation within each litter was divided between developmental age and dose of agonist and nested within replicate litters. When differences were identified by a significant F value, Tukey's test was used to determine age, dose, or interaction differences. Significance was achieved at p < 0.05.
RESULTS
The effects of PG and isoproterenol on cAMP accumulation in newborn d-3 rat lung fibroblasts are illustrated in Figure 1 .
Agonist Loq, (M) 1 (n=3) . . , All agonists tested elicited concentration-dependent increases in cAMP levels (p < 0.05). Increases in cAMP accumulation may be a reflection of either increased cAMP synthesis or decreased cAMP degradation. Because fibroblasts were incubated in the presence of the phosphodiesterase inhibitor, IBMX, the increases observed most probably represent an increase in cAMP production. For each PG tested, 1 0-7 M stimulated a significant increase (p < 0.05) in cAMP accumulation over control (no PG) values. PGE, and the analogues of PGI2 were more effective stimulators of cAMP accumulation than PGE,. For these agonists, the highest cAMP levels achieved at the highest concentrations tested were consistently in the 300-fm0l/~g protein115 min range. Carba PG12 was the most potent stimulator among the prosta- cyclin analogues, with levels reaching approximately 700 fmol/ pg protein115 min. PGEl and isoproterenol were less effective stimulators of cAMP accumulation. Although concentrationdependent increases in cAMP accumulation were observed, the highest accumulation levels were 10 times less than those elicited by PGE, and the prostacyclin analogs at the same agonist concentrations.
To elucidate the effects of advancing developmental age on fibroblast responses to PG, PGE2 and carba PGG were administered to pulmonary fibroblasts cultured from rats at three different ages in the perinatal period: d 20 gestational age and d 1 and d 3 newborn (Figs. 2 and 3) . Both PG elicited concentrationdependent responses at all ages tested (p < 0.05). The fibroblast responsiveness to PGE2 and carba PGlz was similar in d 20 fibroblasts in terms of the highest levels of cAMP accumulation achieved. The overall responsiveness of fibroblasts to PGE2 was not statistically different at the ages tested. However, the ability of carba PG12 to stimulate cAMP accumulation increased with advancing developmental age (p < 0.05), so that newborn d 3 > newborn d 1 > fetal d 20.
Another receptor-mediated mechanism for activating adenylate cyclase is P-adrenergic receptor activation. We therefore examined the effects of the P-adrenergic agonist, isoproterenol, on cAMP accumulation in fibroblasts obtained during fetal and early neonatal development and compared these results with the effects of PG. Figure 4 illustrates the responses elicited for the fetal d-20, newborn d-1, and newborn d-3 cells. Significant (p < 0.05) age-and concentration-dependent increases in cAMP accumulation were evident, and an age-dependent increase (p < 0.05) occurred between d 20 of fetal life and newborn d 1. The relative ability of isoproterenol to stimulate cAMP accumulation was less than that of the PG tested. By d 3, maximum fibroblast production of cAMP by the P-adrenergic agonist was '/20 that of the greatest effects observed with PGG and Ll z that of PGE2 at the highest agonist concentrations tested.
DISCUSSION
The cultured perinatal rat lung fibroblast produces large amounts of prostacyclin and smaller amounts of PGE2 (5). Under conditions in which endogenous arachidonic acid release is stim-ulated by the calcium ionophore, A23 187, PG12 production by fibroblasts can increase 60-fold. Because PG may act on the fibroblast in an autocrine or paracrine fashion to affect pulmonary development, the responsiveness of the fibroblast to changes in PG concentrations merits examination. Many cells respond to PG by altering their intracellular concentrations of CAMP. Therefore, we studied the concentration-dependent and developmental age-dependent accumulation of cAMP in perinatal rat lung fibroblasts to exogenous PG and compared these results with isoproterenol, which increases cAMP production by a separate receptor. The results presented demonstrate both PG-and isoproterenol-dependent cAMP accumulation in perinatal rat lung fibroblasts as a result of acute in vitro exposure. PGEl and the three analogues of prostacyclin evoked larger responses than either PGE2 or isoproterenol. Each PG12 analogue elicited a large cAMP response, which indicates that the cell was responding to prostacyclin rather than the salt or stabilizing moiety of the molecule. A similar pattern of adenylate cyclase responsiveness to different PG was observed by Powell and Solomon (14) in particulate fractions from 29-d fetal (term = 3 1 d) rabbit lungs. They also observed that PGE, and PG12 stimulated adenylate cyclase activity more than PGE2 or other PG. They did not test the effects of any /3-adrenergic agonist.
The minimum concentration at which each PG stimulated a significant increase in cAMP accumulation over baseline was between lo-' and lo-' M. Prostacyclin concentrations of this magnitude are achieved in cell culture by fibroblasts stimulated with A23187 or arachidonic acid (5) . Interestingly, in other experiments performed in our laboratory, it has been observed that PG12 has an inhibitory effect on fibroblast proliferation at M (15) . Therefore, if the effect of PG12 on proliferation is CAMP-mediated, it may suggest that PG causes production of cAMP in excess of the amount required for the biologic response.
These data infer the existence of a prostacyclin receptor in rat perinatal lung fibroblasts. Studies by Dutta-Roy and Sinha (16) document the presence of a single PG receptor that binds PGE, and prostacyclin in human platelets. Occupancy of this receptor results in activation of adenylate cyclase. Interestingly, these investigators found that PGE2, unlike PG12, did not compete with 3H-PGEI for occupation of the PGEI/PG12 receptor, suggesting that PGE2 has a low binding affinity for this receptor. Another study (17) also reported the existence of a PGE/PG12 receptor in bovine adrenal medulla cells, although different PGE classes were not tested for their binding parameters. Additionally, these investigators suggest that this receptor is functionally associated with a pertussis toxin-insensitive G protein and not directly coupled to adenylate cyclase. Alternatively, Gardiner (18) suggests, based on a number of studies in several tissues and species, that three PGE receptor subtypes exist.
The results observed in our study could be explained by either receptor scheme. In the first instance, the roughly equivalent stimulation in CAMP accumulation observed with PGE, and the prostacyclin analogs may be brought about by the binding of prostacyclin analogs and PGE, to the same receptor. Each agonist would have similar efficacy for this receptor. The lower level of stimulation of cAMP accumulation by PGE2 may be the result of a lower affinity and/or decreased efficacy of PGE2 to this receptor. Conversely, the second possibility would be that PGE, and the prostacyclin analogs bind to the same PGE receptor subtype, whereas PGE2 binds to a second PGE receptor subtype.
With the experiments performed in this study, we were unable to distinguish between these two possibilities.
Our data demonstrate that the perinatal rat lung fibroblast increases its responsiveness to both prostacyclin and a p-adrenergic agonist with advancing development. The PG response was specific for PGI2 and significant increases occurred between fetal d 20 and newborn d 1 and again between newborn d 1 and d 3. Powell and Solomon (14) described a developmental agedependent stimulation of adenylate cyclase activity in whole fetal and neonatal rabbit lung particulate fractions by PGEI. The response to PGE, increased significantly by d 24 of gestational age compared with d 21 and increased further until d 27, where it remained constant until newborn d 3 and then increased further until d 8. Therefore, this response is probably more related to lung development than to the process of birth, inasmuch as there are increases in responsiveness after parturition.
The PG12 response differed from the isoproterenol response in two ways. First, there was no subsequent increase in the isoproterenol response between newborn d I and d 3. Second, although the ability of M carba PG12 and isoproterenol to stimulate cAMP accumulation was the same on fetal d 20, by newborn d 3, carba PG12 could stimulate six times more cAMP accumulation than isoproterenol at this concentration. The mechanisms responsible for these observations are unknown. Clearly, candidate steps include changes in receptor number and/or affinity, the relative influence of stimulatory and inhibitory G proteins, or altered coupling of the receptor-G protein-adenylate cyclase complex (1 9). More than just understanding the level of receptor-transduction coupling at which changes occur to account for these observations, it is important to understand the causes of changes in the receptor-transduction coupling mechanism. The increased responsiveness of the fibroblast to prostacyclin and isoproterenol may be related to lung maturation. Central to lung maturation are the changes in the circulating levels of glucocorticoids and the expression of glucocorticoid receptors (20) . Endogenous or exogenous glucocorticoids mature late gestation fetal lungs (2 1 -24). Dexamethasone increases the concentration of p-adrenergic receptors in both rabbit and rat fetal lung explant tissue (25, 26) . In fetal d 19 cultured rat fibroblasts, cortisol treatment enhanced the responsiveness of adenylate cyclase to adrenalin and PGE2 (8) and PG12 (27) . Therefore, it is possible that in vivo changes in circulating glucocorticoids, or in the responsiveness to glucocorticoids, are responsible, in part, for the age-dependent increases in CAMP accumulation in response to prostacyclin and isoproterenol in vitro that we observed. Other factors that contribute to fetal lung maturation, such as simulated fetal breathing movements (28) , thyroid hormones (29), IGF-I, and IGF-II (30, 31) , may act synergistically with cortisol to enhance the responsiveness of the fibroblast to PG. This may account for the observed difference in the relative ability of PG to stimulate cAMP accumulation in our present experimental paradigm compared with that of previous studies (8, 27) in which cortisol only was studied.
The importance of the role of prostacyclin, which generated the greatest cAMP response, in the functioning of the fibroblast remains to be elucidated. It may be related to the morphologic aspects of lung maturation during the perinatal period, inasmuch as carba PG12 slows the rate of fibroblast proliferation (14) .
